Levine James E.
CIK 0001463151
Chief Financial Officer
Filings
5
Latest Mar 13, 2025
Issuers covered
1
Showing
5 of 5
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 0% | -24.8% | -23.2% | -14.6% | -36.4% |
| 90 days | 3 | 33% | -13.1% | -15.6% | +0.5% | -24.3% |
| 180 days | 3 | 0% | -15.4% | -14.0% | -4.2% | -27.9% |
| 365 days | 3 | 0% | -46.6% | -44.3% | -40.4% | -55.0% |
Issuers
Companies where Levine James E. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | 5 | Mar 13, 2025 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|